FDAnews
www.fdanews.com/articles/102111-wockhardt-withdraws-litigation-plans-for-aventis-allegra

Wockhardt Withdraws Litigation Plans for Aventis' Allegra

December 11, 2007
Wockhardt has withdrawn its paragraph IV abbreviated new drug application (ANDA), filed with the USFDA for the marketing rights for Allegra, the world’s best selling anti-allergic drug.
The Financial Express